Does RISANKIZUMAB-RZAA Cause Inflammation? 409 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 409 reports of Inflammation have been filed in association with RISANKIZUMAB-RZAA. This represents 0.6% of all adverse event reports for RISANKIZUMAB-RZAA.
409
Reports of Inflammation with RISANKIZUMAB-RZAA
0.6%
of all RISANKIZUMAB-RZAA reports
3
Deaths
122
Hospitalizations
How Dangerous Is Inflammation From RISANKIZUMAB-RZAA?
Of the 409 reports, 3 (0.7%) resulted in death, 122 (29.8%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 409 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Inflammation?
ADALIMUMAB (7,754)
METHOTREXATE (5,055)
ETANERCEPT (4,459)
RITUXIMAB (3,540)
SECUKINUMAB (3,515)
INFLIXIMAB (3,448)
TOCILIZUMAB (3,371)
ABATACEPT (3,284)
TOFACITINIB (3,241)
LEFLUNOMIDE (3,067)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Inflammation Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA